Literature DB >> 22050666

Managing acute respiratory decompensation in the morbidly obese.

Ahmed S Bahammam1, Suhaila E Al-Jawder.   

Abstract

Morbid obesity adversely affects respiratory physiology, leading to reduced lung volumes, decreased lung compliance, ventilation perfusion mismatch, sleep-disordered breathing and the impairment of ventilatory control, and neurohormonal and neuromodulators of breathing. Therefore, morbidly obese subjects are at increased risk of various pulmonary complications that can present either acutely or chronically. Respiratory failure is one of the most common pulmonary complications related to morbid obesity. Both acute hypoxaemic and hypercapnic respiratory failure are more common among obese patients. The management pathway of respiratory failure depends, to a large extent, on the underlying cause, primarily due to the diversity of the underlying triggering diseases, the pathophysiology and the prognosis associated with each disease. Morbidly obese patients with hypoventilation have an increased risk of acute hypercapnic respiratory failure. Early diagnosis of this disorder and the application of non-invasive ventilation in this group of patients have been shown to improve respiratory parameters, decrease the need for invasive mechanical ventilation and improve survival. Invasive ventilation remains the last life-saving procedure in patients with respiratory failure who do not respond to non-invasive measures. However, due to the abnormal respiratory physiology in obese patients, special precautions are required during intubation, mechanical ventilation and weaning.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Year:  2012        PMID: 22050666     DOI: 10.1111/j.1440-1843.2011.02099.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study.

Authors:  Aljohara S Almeneessier; Samar Z Nashwan; Mostafa Q Al-Shamiri; Seithikurippu R Pandi-Perumal; Ahmed S BaHammam
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.

Authors:  Tapan Behl; Sachin Kumar; Sukhbir Singh; Saurabh Bhatia; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Biomed Pharmacother       Date:  2022-05-24       Impact factor: 7.419

3.  Prevalence, clinical characteristics, and predictors of obesity hypoventilation syndrome in a large sample of Saudi patients with obstructive sleep apnea.

Authors:  Ahmed S BaHammam
Journal:  Saudi Med J       Date:  2015-02       Impact factor: 1.484

Review 4.  Perioperative lung protective ventilation in obese patients.

Authors:  Ana Fernandez-Bustamante; Soshi Hashimoto; Ary Serpa Neto; Pierre Moine; Marcos F Vidal Melo; John E Repine
Journal:  BMC Anesthesiol       Date:  2015-05-06       Impact factor: 2.217

5.  Obesity as an Important Marker of the COVID-19 Pandemic.

Authors:  Irfan A Mir; Renu Soni; Shrey K Srivastav; Inimerla Bhavya; Waseem Q Dar; Malik D Farooq; Vrinda Chawla; Mir Nadeem
Journal:  Cureus       Date:  2022-01-19

6.  Left ventricular diastolic dysfunction in patients with obesity hypoventilation syndrome.

Authors:  Hadil A Al Otair; Fayez Elshaer; Alaa Elgishy; Samar Z Nashwan; Aljohara S Almeneessier; Awad H Olaish; Ahmed S BaHammam
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.